Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 20, 2013
Very short course of triple therapy including telaprevir for chronic hepatitis C: a possible strategy in selected patientsGiampaolo Corti, Elena Salomoni, Filippo Baragli
Scandinavian Journal of Infectious Diseases|November 2, 2012
Chronic hepatitis C virus hepatitis and psoriasis: no longer a contraindication to interferon use in the era of biological agents?Filippo Bartalesi, Elena Salomoni, Annalisa Cavallo, et al.
American Journal of Orthopedics (Belle Mead, N.J.)|February 23, 2013
Candida glabrata prosthetic hip infectionFilippo Bartalesi, Stefania Fallani, Elena Salomoni, et al.
European Journal of Pharmacology|April 18, 2017
Non-invasive assessment of liver fibrosis in patients with HBV-related chronic liver disease undergoing antiviral treatment: A preliminary studyCristina Stasi, Elena Salomoni, Umberto Arena, et al.
Infection and Drug Resistance|August 9, 2020
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World CohortPaolo Bonfanti, Andrea De Vito, Elena Ricci, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 13, 2020
Risk factors for non-invasive/invasive ventilatory support in patients with COVID-19 pneumonia: A retrospective study within a multidisciplinary approachLorenzo Roberto Suardi, Carlo Pallotto, Sara Esperti, et al.
AIDS (London, England)|October 22, 2024
Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people with HIV from the STOPSHIV cohortGiuseppe Vittorio De Socio, Elena Ricci, Stefania Piconi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 9, 2026
Smoking Cessation in People Living With HIV: Results From Italian STOPSHIV Project CohortDebora Altobelli, Elena Ricci, Paolo Maggi, et al.
Drug Design, Development and Therapy|December 28, 2020
The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid ProfileNicola Squillace, Elena Ricci, Barbara Menzaghi, et al.
Pageof 2